Global Hypercalcemia Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 119 pages | ID: G5056E36D00EN
GlobalInfoResearch

Abstracts

Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.

Scope of the Report:

This report studies the Hypercalcemia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hypercalcemia Treatment market by product type and applications/end industries.

The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.

The growing preference for combination therapy is estimated to drive the growth prospects for the global hypercalcemia treatment market until the end of 2023. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.

The global Hypercalcemia Treatment market is valued at 8590 million USD in 2017 and is expected to reach 15500 million USD by the end of 2023, growing at a CAGR of 10.3% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hypercalcemia Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

• AbbVie
• Amgen
• Merck
• Novartis
• OPKO Health

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Bisphosphonates
• Glucocorticoids
• Calcimimetic Agents

Market Segment by Applications, can be divided into

• Mild Hypercalcemia 
• Moderate Hypercalcemia 
• Severe Hypercalcemia
  
  

Contents

1 HYPERCALCEMIA TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Hypercalcemia Treatment
1.2 Classification of Hypercalcemia Treatment by Types
  1.2.1 Global Hypercalcemia Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Hypercalcemia Treatment Revenue Market Share by Types in 2017
  1.2.3 Bisphosphonates
  1.2.4 Glucocorticoids
  1.2.5 Calcimimetic Agents
1.3 Global Hypercalcemia Treatment Market by Application
  1.3.1 Global Hypercalcemia Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Mild Hypercalcemia
  1.3.3 Moderate Hypercalcemia
  1.3.4 Severe Hypercalcemia
1.4 Global Hypercalcemia Treatment Market by Regions
  1.4.1 Global Hypercalcemia Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Hypercalcemia Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Hypercalcemia Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hypercalcemia Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Hypercalcemia Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hypercalcemia Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Hypercalcemia Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 AbbVie
  2.1.1 Business Overview
  2.1.2 Hypercalcemia Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 AbbVie Hypercalcemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
  2.2.1 Business Overview
  2.2.2 Hypercalcemia Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Amgen Hypercalcemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
  2.3.1 Business Overview
  2.3.2 Hypercalcemia Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Merck Hypercalcemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 Hypercalcemia Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis Hypercalcemia Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 OPKO Health
  2.5.1 Business Overview
  2.5.2 Hypercalcemia Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 OPKO Health Hypercalcemia Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HYPERCALCEMIA TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Hypercalcemia Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Hypercalcemia Treatment Players Market Share
  3.2.2 Top 10 Hypercalcemia Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL HYPERCALCEMIA TREATMENT MARKET SIZE BY REGIONS

4.1 Global Hypercalcemia Treatment Revenue and Market Share by Regions
4.2 North America Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA HYPERCALCEMIA TREATMENT REVENUE BY COUNTRIES

5.1 North America Hypercalcemia Treatment Revenue by Countries (2013-2018)
5.2 USA Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE HYPERCALCEMIA TREATMENT REVENUE BY COUNTRIES

6.1 Europe Hypercalcemia Treatment Revenue by Countries (2013-2018)
6.2 Germany Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
6.4 France Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC HYPERCALCEMIA TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Hypercalcemia Treatment Revenue by Countries (2013-2018)
7.2 China Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
7.5 India Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA HYPERCALCEMIA TREATMENT REVENUE BY COUNTRIES

8.1 South America Hypercalcemia Treatment Revenue by Countries (2013-2018)
8.2 Brazil Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE HYPERCALCEMIA TREATMENT BY COUNTRIES

9.1 Middle East and Africa Hypercalcemia Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Hypercalcemia Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL HYPERCALCEMIA TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Hypercalcemia Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Hypercalcemia Treatment Market Forecast by Type (2018-2023)
10.3 Bisphosphonates Revenue Growth Rate (2013-2023)
10.4 Glucocorticoids Revenue Growth Rate (2013-2023)
10.5 Calcimimetic Agents Revenue Growth Rate (2013-2023)

11 GLOBAL HYPERCALCEMIA TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Hypercalcemia Treatment Revenue Market Share by Application (2013-2018)
11.2 Hypercalcemia Treatment Market Forecast by Application (2018-2023)
11.3 Mild Hypercalcemia Revenue Growth (2013-2018)
11.4 Moderate Hypercalcemia Revenue Growth (2013-2018)
11.5 Severe Hypercalcemia Revenue Growth (2013-2018)

12 GLOBAL HYPERCALCEMIA TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Hypercalcemia Treatment Market Size Forecast (2018-2023)
12.2 Global Hypercalcemia Treatment Market Forecast by Regions (2018-2023)
12.3 North America Hypercalcemia Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Hypercalcemia Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hypercalcemia Treatment Revenue Market Forecast (2018-2023)
12.6 South America Hypercalcemia Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hypercalcemia Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hypercalcemia Treatment Picture
Table Product Specifications of Hypercalcemia Treatment
Table Global Hypercalcemia Treatment and Revenue (Million USD) Market Split by Product Type
Figure G